1. Home
  2. CMS vs RMD Comparison

CMS vs RMD Comparison

Compare CMS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CMS Energy Corporation

CMS

CMS Energy Corporation

HOLD

Current Price

$73.92

Market Cap

24.6B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$197.79

Market Cap

28.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMS
RMD
Founded
1987
1989
Country
United States
United States
Employees
8350
10600
Industry
Power Generation
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.6B
28.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CMS
RMD
Price
$73.92
$197.79
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$80.80
$292.56
AVG Volume (30 Days)
2.7M
1.6M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
3.05%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.06
$10.60
Revenue Next Year
$4.67
$7.41
P/E Ratio
$21.28
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$68.64
$180.27
52 Week High
$80.36
$293.81

Technical Indicators

Market Signals
Indicator
CMS
RMD
Relative Strength Index (RSI) 44.47 47.34
Support Level $71.85 $182.46
Resistance Level $75.41 $260.21
Average True Range (ATR) 1.48 6.06
MACD -0.31 -0.52
Stochastic Oscillator 1.12 23.62

Price Performance

Historical Comparison
CMS
RMD

About CMS CMS Energy Corporation

CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: